ALLIANCEBERNSTEIN L.P. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 147 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$7,102,000
+486.5%
206,146
+184.3%
0.00%
+300.0%
Q2 2020$1,211,000
+15.9%
72,5000.0%0.00%0.0%
Q1 2020$1,045,000
-98.5%
72,500
-96.5%
0.00%
-97.4%
Q4 2019$69,307,000
+55.4%
2,070,715
-2.8%
0.04%
+39.3%
Q3 2019$44,608,000
+1.0%
2,130,261
+0.4%
0.03%
+3.7%
Q2 2019$44,168,000
-6.8%
2,121,399
+0.1%
0.03%
-12.9%
Q1 2019$47,370,000
+1.8%
2,119,475
+8.9%
0.03%
-11.4%
Q4 2018$46,540,000
-10.9%
1,945,670
+1.6%
0.04%
+2.9%
Q3 2018$52,260,000
+27.5%
1,915,689
+25.7%
0.03%
+17.2%
Q2 2018$40,977,000
-3.3%
1,523,871
+14.4%
0.03%
-6.5%
Q1 2018$42,396,000
-19.9%
1,331,941
-4.9%
0.03%
-18.4%
Q4 2017$52,959,000
+219.6%
1,400,281
+109.5%
0.04%
+216.7%
Q3 2017$16,568,000
+15.6%
668,354
-4.2%
0.01%
+9.1%
Q2 2017$14,338,000
-12.1%
697,392
-7.1%
0.01%
-15.4%
Q1 2017$16,311,000
+11.4%
750,640
+4.9%
0.01%
+8.3%
Q4 2016$14,637,000
+41.2%
715,727
+3.5%
0.01%
+33.3%
Q3 2016$10,369,000
+29.1%
691,242
-6.9%
0.01%
+28.6%
Q2 2016$8,031,000
-7.0%
742,217
+16.5%
0.01%0.0%
Q1 2016$8,637,000
-30.7%
636,971
-5.6%
0.01%
-36.4%
Q4 2015$12,455,000
-18.8%
675,050
+11.4%
0.01%
-15.4%
Q3 2015$15,345,000606,0290.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TLP GROUP LLC 2,781,259$51,314,00040.87%
Foresite Capital Management II, LLC 4,087,900$75,422,00025.29%
Aisling Capital LLC 2,990,000$55,166,0009.51%
Foresite Capital Management III, LLC 355,020$6,550,0005.81%
RA Capital Management 790,200$14,579,0001.44%
SECTORAL ASSET MANAGEMENT INC 982,133$18,120,0000.77%
Rock Springs Capital Management LP 259,646$4,790,0000.36%
Palo Alto Investors LP 325,599$6,007,0000.33%
EMERALD MUTUAL FUND ADVISERS TRUST 282,355$5,209,0000.28%
EMERALD ADVISERS, LLC 270,358$4,988,0000.24%
View complete list of AIMMUNE THERAPEUTICS INC shareholders